BrainsWay Announces its Multicenter Smoking Cessation Study Has Reached Target Enrollment

BrainsWay (NASDAQ:BWAY) has announced it has reached its target recruitment for its multicenter study for the safety and efficacy of...

BrainsWay’s TMS Device is Reshaping Brain Disorder Treatments

INN spoke with BrainsWay's Joseph Perekupka about how the company's deep TMS device treats depression and OCD.

Which Life Science IPOs is the Government Shutdown Affecting?

Initial public offerings meant to take place are facing a huge barrier due to the ongoing US government shutdown.